Trademark Search in Canada

M²PE

View On IC.GC.CA

REGISTERED

on 4 Sept 2024

Last Applicant/ Owned by

CRESCITA THERAPEUTICS INC.

6733 Mississauga Road, Suite 610Mississauga

ONTARIO

L5N6J5

Serial Number

1945860 filed on 12^th Feb 2019

Registration Number

TMA1254360 registered on 4^th Sept 2024

Registration expiry Date

4^th Sept 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

M²PE

Trademark usage description

skin care preparations; non-medicated skin care preparations; cosmeceutical preparations, namely exfoliants, moisturizers, creams, gels, lotions, powd Read More

Classification Information

Class [003]
Skin care preparations; non-medicated skin care preparations; cosmeceutical preparations, namely exfoliants, moisturizers, creams, gels, lotions, powders, oils, extracts, serums, peels, masks, patches, balms, ointments, and pastes for treating the skin, hair, scalp, lips and nails; cosmetic preparations for skin, scalp, hair, nail, lips, and skin, scalp, hair, nail, lip treatments; skin care preparations, namely face and body creams, face and body gels, lotions, powders, oils, extracts, serums, sunscreens, peels, masks, patches, skin lighteners, balms, ointments, and pastes; cosmetic skin care preparations; cosmetic slimming preparations; cosmetic sun-protecting preparations; hair care preparations, namely shampoos; non-medicated active skin care preparations for dermatological applications; cosmeceutical preparations for improved topical delivery of active ingredients into and through the skin containing actives, and cosmetic preparations for the skin, scalp, hair, nail, lips, and hair care preparations, scalp care preparations, lip care preparations, nail care preparations, skin care preparations; active-containing dermatological preparations, namely, cannabinoids, beta carotene, beta-caryophyllene and lidocaine.

Classification kind code

Class [005]
Pharmaceutical preparations for treating and preventing skin diseases, diseases associated with the dermis, epidermis, underlying tissue, namely, connective, muscle, joint, nervous tissue, and diseases that require systemic treatment, namely psoriasis, atopic dermatitis, urticaria, arthritis, ichthyosis, scleroderma, pemphigus, Hidradenitis Suppurativa (HS), cancer, fibromyalgia, lupus, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, diabetes, Crohn's disease, hyper-sweating, fungal infections, athlete's foot, rashes, alopecia, sunburns, shingles, birthmarks and hormonal imbalances associated with menopause, pregnancy and post-partum; pharmaceutical preparations for topical and transdermal application, namely skin creams, skin gels, lotions, powders, oils, extracts, serums, peels, masks, patches, balms, ointments, and pastes for treating and preventing skin diseases, diseases associated with the dermis, epidermis, underlying tissue, namely, connective, muscle, joint, nervous tissue, and diseases that require systemic treatment, namely psoriasis, atopic dermatitis, urticaria, arthritis, ichthyosis, scleroderma, pemphigus, Hidradenitis Suppurativa (HS), cancer, fibromyalgia, lupus, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, diabetes, Crohn's disease, hyper-sweating, fungal infections, athlete's foot, rashes, alopecia, sunburns, shingles, birthmarks and hormonal imbalances associated with menopause, pregnancy and post-partum; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for use in dermatology, namely cold sores, skin irritations, and skin diseases; pain relief preparations; pharmaceutical preparations containing active ingredients for treating and preventing skin diseases, diseases associated with the dermis, epidermis, underlying tissue, namely, connective, muscle, joint, nervous tissue, and diseases that require systemic treatment, namely psoriasis, atopic dermatitis, urticaria, arthritis, ichthyosis, scleroderma, pemphigus, Hidradenitis Suppurativa (HS), cancer, fibromyalgia, lupus, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, diabetes, Crohn's disease, hyper-sweating, fungal infections, athlete's foot, rashes, alopecia, sunburns, shingles, birthmarks and hormonal imbalances associated with menopause, pregnancy and post-partum; prescription and non-prescription pharmaceutical preparations containing actives, namely, cannabinoids, beta carotene, beta-caryophyllene and lidocaine for treating and preventing skin diseases, diseases associated with the dermis, epidermis, underlying tissue, namely, connective, muscle, joint, nervous tissue, and diseases that require systemic treatment, namely psoriasis, atopic dermatitis, urticaria, arthritis, ichthyosis, scleroderma, pemphigus, Hidradenitis Suppurativa (HS), cancer, fibromyalgia, lupus, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, diabetes, Crohn's disease, hyper-sweating, fungal infections, athlete's foot, rashes, alopecia, sunburns, shingles, birthmarks and hormonal imbalances associated with menopause, pregnancy and post-partum; dermatological preparations, namely, vitamin, preservative and antioxidant containing skin care preparations; dermatological skin care preparations for the treatment of acne, actinic keratosis, allergic eczema, atopic dermatitis, basal cell carcinoma, blisters, carbuncles, cellulitis, cold sores, contact dermatitis, eczema, hemangiomas, hives, ichthyosis vulgaris, impetigo, keloids, keratosis pilaris, lupus, melanoma, melasma, psoriasis, ringworm, rosacea, seborrheic dermatitis, seborrheic keratosis, skin tags, squamous cell carcinoma, tinea pedis, vitiligo, and warts.

Classification kind code

Mark Details

Serial Number

1945860

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 191 on 14^th Jun 2024	Registration Fee Notice Sent
Submitted for opposition 42 on 27^th Mar 2024	Advertised
Submitted for opposition 27 on 29^th Feb 2024	Approval Notice Sent
Submitted for opposition 26 on 29^th Feb 2024	Approved
Submitted for opposition 15 on 8^th May 2023	Correspondence Created
Submitted for opposition 22 on 9^th Aug 2022	Search Recorded
Submitted for opposition 20 on 9^th Aug 2022	Examiner's First Report
Submitted for opposition 31 on 14^th Feb 2019	Formalized
Submitted for opposition 1 on 13^th Feb 2019	Created
Submitted for opposition 30 on 12^th Feb 2019	Filed